{"id":28810,"date":"2025-07-02T09:44:40","date_gmt":"2025-07-02T13:44:40","guid":{"rendered":"https:\/\/www.rbcwealthmanagement.com\/en-ca\/?post_type=rbcwm_podcast&p=28810"},"modified":"2025-07-02T11:40:25","modified_gmt":"2025-07-02T15:40:25","slug":"episode-65-closing-the-gaps-in-womens-health-research","status":"publish","type":"rbcwm_podcast","link":"https:\/\/www.rbcwealthmanagement.com\/en-ca\/podcasts\/episode-65-closing-the-gaps-in-womens-health-research","title":{"rendered":"Closing the gaps in women\u2019s health research"},"content":{"rendered":"\n
\n

This podcast is part of a series focused on women\u2019s health, in partnership with Women\u2019s Brain Health Initiative (WBHI)<\/a> . <\/p>\n\n\n\n

We aim to shine a light on gender inequalities, provide insights, and actionable steps Canadians can take to advocate for their own health and longevity.\u00a0Learn more about WBHI and discover insights from leading researchers, clinicians and advocates at the Women’s Brain Health Summit<\/a>.\u00a0<\/p>\n<\/div>\n\n\n\n

<\/div>\n\n\n\n

Leanne Kaufman:<\/strong><\/p>\n\n\n\n

From the medications we take to the medical devices used to treat us, it\u2019s shocking to think that sex and gender considerations have often been ignored in the development and prescription of life-saving tools.<\/p>\n\n\n\n

Women specifically have been ignored in research and trials, and the difference in the sexes is frequently disregarded in treatment options.<\/p>\n\n\n\n

Luckily, there is a body of work now happening across Canada that recognizes the gaps created by a one-size-fits-all approach, and we are lucky enough to have one of the leading researchers in this space joining us today. We\u2019ll be diving into the gaps in women\u2019s health research, exploring the implications of this lack of research, and examining what it means for Canadian women and their families.<\/p>\n\n\n\n

Hello. I\u2019m Leanne Kaufman and welcome to RBC Wealth Management Canada\u2019s Matters Beyond Wealth. <\/p>\n\n\n\n

With me today is Dr. Angela Kaida, Scientific Director of the Institute of Gender and Health<\/a>, who specializes in gender, sex, and health research. I had the privilege of meeting Dr. Kaida when she spoke at an event hosted by the Women\u2019s Brain Health Initiative<\/a> and I\u2019m so excited to have her bring her expertise to us here on this podcast.<\/p>\n\n\n\n

Dr. Kaida, welcome. I\u2019m so glad and fortunate that our paths did cross. And now we get to continue the conversation around why, as I\u2019ve heard Dr. Stacy Sims in the U.S. say, \u201cWomen are not small men\u201d, particularly when it comes to our health, and why this all matters beyond wealth.<\/p>\n\n\n\n

Angela Kaida:<\/strong>   <\/p>\n\n\n\n

Thanks so much, Leanne. So happy to be here.<\/p>\n\n\n\n

Leanne Kaufman:<\/strong>            <\/p>\n\n\n\n

So maybe you can start by telling us a little bit about the Institute of Gender and Health and your role there.<\/p>\n\n\n\n

Angela Kaida:   <\/strong><\/p>\n\n\n\n

Sure. Well, thank you, Leanne.<\/p>\n\n\n\n

So the Institute of Gender and Health is actually one of thirteen scientific institutes that make up the Canadian Institutes of Health Research or CIHR. So CIHR is Canada, our health research funding agency.<\/p>\n\n\n\n

CIHR\u2019s role really is to fund the best necessary research across all pillars of health sciences. So we kind of talk about that as biomedical research, clinical sciences research, health systems and services research, population health, public health, environmental health research.<\/p>\n\n\n\n

And so, we really think of research as having the power to change lives overall. And for us at the CIHR Institute of Gender and Health, we have a very specific mandate, which is about fostering research excellence regarding the influence of sex and gender on our health, but also to apply what we\u2019re learning to identify and address the pressing health challenges that are facing women, men, gender-diverse people, boys, girls across the country.<\/p>\n\n\n\n

My role is, I am the Scientific Director of the CIHR Institute of Gender and Health<\/a>.<\/p>\n\n\n\n

Leanne Kaufman:<\/strong>            <\/p>\n\n\n\n

And I\u2019m so glad to hear that it\u2019s not just the research, but the application of the research because that\u2019s where the meaning probably happens to those of us listening and on the receiving end of all the great work that you\u2019re doing.<\/p>\n\n\n\n

So why do you think it\u2019s important? It sounds like such a silly question. But why is it important to study sex and gender as part of research? And maybe you could share with us some examples of where it\u2019s made a real difference.<\/p>\n\n\n\n

Angela Kaida:<\/strong>   <\/p>\n\n\n\n

Yeah. It\u2019s actually not a silly question. And sometimes it doesn\u2019t seem obvious in academic language. But I think for each one of us, as a person, we understand where there\u2019s value here.<\/p>\n\n\n\n

So I\u2019m going to first just start by distinguishing sex and gender because I think there\u2019s so much confusion right now about why do we talk about sex and gender as separate terms.<\/p>\n\n\n\n

So in the first place, sex is really a biological attribute. It\u2019s about our chromosomes, our genes, our hormones, our physiology, our anatomy, our reproductive organs and capacity. So those are\u2014both of humans, of animals, we all have a sex.<\/p>\n\n\n\n

Whereas gender is really socially constructed. Maybe it\u2019s about how I identify, but it\u2019s much, much more than that. It\u2019s also about gender norms; expectations of our behaviour given our gender; how we relate to each other; what society expects of people of one gender or another; whose lives we value or value less because of our gender.<\/p>\n\n\n\n

So gender is a really messy construct. But I think we live it because we are sexed bodies in a gendered society.<\/p>\n\n\n\n

And so both of these terms, when it comes to people, are related, but they\u2019re not exactly the same.<\/p>\n\n\n\n

So when you asked about, why is it important to study sex and gender in any research, it\u2019s because some of what we learn about treatments, about diagnoses, about vaccines, about cures are affected by aspects of our sex. There\u2019s a lot of examples about this in immunology, in particular.<\/p>\n\n\n\n

And some of what we experience is about our gender, so, how we access care; who believes us when we say we have symptoms of pain or depression or mental health challenges; how are healthcare systems set up that might be better able to serve people of different genders or are actually worse at serving people of different genders.<\/p>\n\n\n\n

So that\u2019s hopefully a pretty accessible understanding about why sex and gender matter in our health. But it really plays out in the sense of, if most of our scientific evidence base comes from research that has really predominantly included male animal models or male cells or men\u2019s experiences, then what we\u2019ve been doing is trying to generalize those findings to female bodies and to women\u2019s experiences and gender-diverse people\u2019s experiences.<\/p>\n\n\n\n

And there\u2019s gaps in that translation. We\u2019ve all experienced that.<\/p>\n\n\n\n

So we have data that tells us that for hundreds of conditions, women experience an average of two years of delay of diagnosis for that condition. Because women\u2019s experiences are just so underrepresented in that evidence base.<\/p>\n\n\n\n

Leanne Kaufman:<\/strong>            <\/p>\n\n\n\n

Well, I mean, you did do an excellent job. Thank you for breaking it down.<\/p>\n\n\n\n

And you mentioned that these hundreds of examples where the research on only men has been done and how women get impacted by being delayed in diagnoses and so on. How does it impact actual lifespans? If we\u2019re two years late or a couple of years, whatever the case may be, late in getting diagnosed because we haven\u2019t been the subject of the research and so on, does it have an impact on overall lifespans?<\/p>\n\n\n\n

Angela Kaida:<\/strong>   <\/p>\n\n\n\n

So this is where it gets really even more interesting.<\/p>\n\n\n\n

So what we know is that, on average, women do live longer. So lifespan, women do live, on average, have a longer lifespan than men. And I\u2019ll only speak about men and women in this example because we just don\u2019t have a lot of data around folks who may identify outside of the women and men binary. But that part we know is true.<\/p>\n\n\n\n

The interesting part is when we talk about health span, the language of health span. And so women will spend an average of nine years longer in poor health relative to men.<\/p>\n\n\n\n

So we might have a longer lifespan, but our health span is worse.<\/p>\n\n\n\n

And much of that time that we spend in poor health affects us during what would otherwise be very productive years of our lives. And whether that\u2019s in the phase of perimenopause or menopause or our early years of being a senior, under-addressed health issues, including chronic pain, including depression and mental health, including our higher risk and consequence of Alzheimer\u2019s, lower back pain, various forms of arthritis, those are really compromising women\u2019s health span, our contributions to our families or to our societies.<\/p>\n\n\n\n

And these are questions that we need research to help us understand and then, as you said, apply what we learn.<\/p>\n\n\n\n

Leanne Kaufman:<\/strong>            <\/p>\n\n\n\n

Fantastic. I\u2019m so glad you\u2019re doing this work.<\/p>\n\n\n\n

Since you\u2019ve been named the Scientific Director of the Institute or going back previous to you in the role even, what sort of progress can you tell us about that\u2019s been made in this space?<\/p>\n\n\n\n

Angela Kaida:<\/strong>   <\/p>\n\n\n\n

Yeah. And this is really the work of my predecessors, other Scientific Directors, but I\u2019m so happy to brag about it on their behalf. But I think really, CIHR has been a world leader in requiring all health researchers who are seeking funding from CIHR to talk about the sex and gender considerations in their research, as in, this is mandatory in Canada. So if you are doing research on a new\u2014you\u2019re testing a new cancer drug, or you\u2019re testing new ways to diagnose postpartum depression, or you\u2019re doing research on active transportation in cities, it doesn\u2019t matter. What we are requiring is that if you are seeking funding from the Canadian Institutes of Health Research, you have to consider the sex and gender considerations of your research question.<\/p>\n\n\n\n

And then we require the peer reviewers\u2014so within science, peer review is everything. So the peer reviewers are then required to assess, have you adequately considered sex and gender in your research, and include that information on the score, so whether or not you\u2019re going to be funded to do the work you\u2019re proposing.<\/p>\n\n\n\n

So that policy has really led to a remarkable increase, as you can imagine, in the proportion of funded studies that do consider sex and gender. So that is progress and that matters.<\/p>\n\n\n\n

Now our attention is really turning to, okay, so folks said that they were going to do sex and gender considerations in their research; did they actually do it? Do they publish their findings in such a way that enables us to see the data by sex and gender considerations? Do they interpret their findings sufficiently along sex and gender considerations?<\/p>\n\n\n\n

So that is all, I would say, work in progress.<\/p>\n\n\n\n

Leanne Kaufman:<\/strong><\/p>\n\n\n\n

And it\u2019s just so hard to believe, as a recipient of the healthcare system, that this is new. Isn\u2019t it? I mean, really, it is quite alarming.<\/p>\n\n\n\n

I\u2019ve read that much of your work also considers how sex and gender intersect with societal factors and some of the social determinants of health, as part of what I\u2019ve read in some of your work, what you call \u201cprecision medicine\u201d.<\/p>\n\n\n\n

Can you explain a little bit more what you mean by this?<\/p>\n\n\n\n

Angela Kaida:   <\/strong><\/p>\n\n\n\n

Yeah. So I think this is really exciting. And I think probably your listeners can really connect with the idea of \u201cprecision medicine\u201d. We sometimes call it \u201cpersonalized medicine\u201d.<\/p>\n\n\n\n

And so this is really a healthcare approach where medical decisions are tailored to an individual or a patient\u2019s unique circumstances or unique characteristics.<\/p>\n\n\n\n

So for instance, if you are a female of a certain age, you have an ancestry background of South Asian, you have a life experience that means that you\u2019ve lived in relative comfort, you don\u2019t have problems accessing safe and secure food or housing, all of those features can bear into what type of care that you receive.<\/p>\n\n\n\n

And so that personalized or precision-medicine approach really kind of blows up the one size fits all. Right? It really says to us, we can be more sophisticated than that. We can really examine our data and examine the evidence base to provide more specific guidance on treatment, on prevention strategies, on your actual risk for different conditions based on this data that includes some biology and includes some social considerations.<\/p>\n\n\n\n

But we can only do that if we have a scientific evidence base that accounts for those factors. So we can\u2019t get to personalized medicine if we\u2019re continuing to do research that is one size doesn\u2019t fit all\u2014but that kind of obscures some of those really important nuances. But if we can do the research that helps us examine these different factors that matter in a nuanced and complex way, then we can get to that type of personalized medicine that I think we all want and that we all deserve really.<\/p>\n\n\n\n

Leanne Kaufman:<\/strong>            <\/p>\n\n\n\n

I couldn\u2019t agree more. And so would you consider wealth one of those societal factors?<\/p>\n\n\n\n

Angela Kaida:   <\/strong><\/p>\n\n\n\n

Yes. I mean, of course. I think intuitively we understand that and the data shows us that as well.<\/p>\n\n\n\n

But the relationship between wealth and health is sometimes a bit more interesting than we think.<\/p>\n\n\n\n

So for instance, on an individual level, we know that if you have wealth, I guess is the language that we\u2019ll use, you\u2019re more likely to have good health. You can access healthcare services. You can access health information anytime that treatments require co-pay. That\u2019s not a barrier for you. You can live in healthy neighbourhoods that provide access to active living, all of those things that we know that individual wealth confers to an individual as far as their health.<\/p>\n\n\n\n

But what\u2019s also interesting is, it\u2019s not just individual wealth that matters; it\u2019s wealth at a population level and how wealth is distributed in a population. So even living in a very unequal society when it comes to health means that population health is worse than for people who live in a more equally distributed country or society when it comes to their wealth.<\/p>\n\n\n\n

So it\u2019s just a reflection that wealth works in many ways on an individual level, but also at a population level in terms of how we distribute access to resources and wealth in a country.<\/p>\n\n\n\n

Leanne Kaufman:<\/strong>            <\/p>\n\n\n\n

So by way of example then, comparing a country like Canada where it\u2019s a little more evenly distributed perhaps from an access perspective to a model like the US, which may have bigger gaps. Is that what you\u2019re getting at with the population level?<\/p>\n\n\n\n

Angela Kaida:<\/strong>   <\/p>\n\n\n\n

Exactly. And there\u2019s a lot of countries that we can look at, but that\u2019s such a great\u2014a really helpful example.<\/p>\n\n\n\n

So the U.S. spends the most on health as a country, but it doesn\u2019t deliver on population-level health outcomes. So their life expectancy is much lower than you would expect for a country that spends what it spends on health. It\u2019s much lower than what you might expect for a country which is, I guess, maybe the richest country in the world; I\u2019m not sure exactly where we put it nowadays. But relative to Canada where we spend less, but we deliver on higher health outcomes for our population. And that\u2019s because of how I think that health and wealth, partly, how health and wealth are distributed in this country.<\/p>\n\n\n\n

Leanne Kaufman:<\/strong>            <\/p>\n\n\n\n

Yeah. That\u2019s very helpful.<\/p>\n\n\n\n

So for our listeners, I think one of the things we sometimes might struggle with as patients or as family members of patients is self-advocacy. And if this is another tool that we now have to think about how sex and gender may impact the path that we are on, whatever that may be from a health prevention or disease treatment perspective, do you have any tips for everyone about how to be an advocate in this particular area of healthcare?<\/p>\n\n\n\n

Angela Kaida:<\/strong>   <\/p>\n\n\n\n

Our institute is a national and, I think, world leader in sex, gender, and health research, the importance of the work, how to do it better, how we can apply what we\u2019ve learned, the value of it.<\/p>\n\n\n\n

And as we\u2019ve sort of advanced work in this area, it\u2019s been pretty clear that this underinvestment in women\u2019s health and women\u2019s health research needs a really targeted focus. So we really needed to look at, if we know that women\u2019s health has been underfunded, what has that led to?<\/p>\n\n\n\n

And so we\u2019ve looked at our own data to find that across CIHR, really a very small proportion of health research funding has gone specifically to female-specific conditions or those conditions that disproportionately or differently affect women, if that makes sense.<\/p>\n\n\n\n

So if I can give you\u2014I think, the female specific, we all sort of have an idea of that, of whether that\u2019s endometriosis or ovarian cancer or menopause, perimenopause, et cetera. But there are also a number of conditions that we now know, even like heart disease, that affect women so differently that the symptomology that many of us may have in our minds of a heart attack\u2014you clutch your chest, fall to the ground\u2014are not symptoms that women experiencing heart disease, generally experience.<\/p>\n\n\n\n

So we\u2019ve got these conditions that affect all of us, but they look so different in women.<\/p>\n\n\n\n

So we\u2019ve been leading what I think of as a first-in-a-generation investment in women\u2019s health research in this country. And that has started with a $20 million investment from the federal government to address areas of high-need underinvestment in women\u2019s health, which honestly is, like, all of them, but, that\u2019s where we started. And then we\u2019ve been building on that with some additional investments of $50 million in other areas of women\u2019s health research, including sexual health, including women and HIV, including stroke, including conditions of long COVID.<\/p>\n\n\n\n

So we\u2019re really trying to invest and build Canada\u2019s contribution to women\u2019s health research. And because we have, I think, some of the world\u2019s greatest scientists here in Canada, this has been an absolute joy for me in my position to be able to support these ideas, this creativity, this high-impact work.<\/p>\n\n\n\n

But if you asked us, what can listeners do\u2014I think that was coming back to your question. What can listeners do to advocate for themselves, advocate for this work?<\/p>\n\n\n\n

I think there\u2019s the obvious answers that I\u2019m sure lots of people will share about staying involved and read more, get informed. Okay. I think we know that stuff.<\/p>\n\n\n\n

But I also want to do a plug for participating in research. And so if you are at your doctor\u2019s office or you see a flyer or something comes along your way, you\u2019re thinking, \u00ab Yeah, gosh, I\u2019m not sure I\u2019ve got time for that \u00bb; participate in research. Because providing your experience, your voice, I guess, your data, your story, to be part of what we\u2019re learning about women\u2019s health in this country is so important. And the more people that we have participating in research, the more diverse the people are who participate in our research, just the richer our knowledge base is going to be to influence better health outcomes for all of us.<\/p>\n\n\n\n

So as a researcher, I have to make that plug and encouragement to say, you will learn a lot. You will connect with an incredible health research community across this country. And I think being part of research helps you understand, helps us understand\u2014I mean, the royal us\u2014the value of research.<\/p>\n\n\n\n

Leanne Kaufman:<\/strong>            <\/p>\n\n\n\n

Is there a centralized depository of the research that\u2019s going on where they\u2019re looking for volunteers, where people could, if they\u2019re interested in participating, either broadly or on a specific topic?<\/p>\n\n\n\n

Angela Kaida:<\/strong>   <\/p>\n\n\n\n

So there\u2019s no easy way to do that right now. Okay? I\u2019m sorry to tell you and the listeners. There\u2019s no easy way to do that right now.<\/p>\n\n\n\n

But one of the things that we have done within the last year is to fund what is called the Pan-Canadian Women\u2019s Health Research Coalition<\/a>. Doesn\u2019t matter. But the point is to do exactly what you\u2019re saying, which is that there is a lot of knowledge out there. There are a lot of ways to learn more from experts across this country, but it\u2019s convoluted to access.<\/p>\n\n\n\n

And so one of the roles of this coalition is to be that central point, is to say, okay, here is the incredible work happening across the country. Here are research opportunities for you to participate in or to be aware of. Here are some leading experts who are doing work in areas that might be really relevant to you personally in your life. Here\u2019s the opportunities to hear from them or read their work or be part of a larger movement.<\/p>\n\n\n\n

And so that work is being led by what we\u2019ve called a coordinating centre in women\u2019s health research. And so, as that, they\u2019re developing a website and a repository. So I\u2019ll send you what is currently up there and then it\u2019s a watch-this-space type of invitation.<\/p>\n\n\n\n

Leanne Kaufman:<\/strong>            <\/p>\n\n\n\n

That\u2019s amazing. And maybe we\u2019ll be able to add the details as they come in to the episode webpage for this episode as well.<\/p>\n\n\n\n

Oh my goodness. I feel like I could talk to you for the rest of the day, frankly, because I have so many questions. But we want to be mindful of your time and the time of our listeners.<\/p>\n\n\n\n

My last question is typically, if you hope listeners remember just one thing from this conversation what would that be, but, what\u2019s something we haven\u2019t talked about yet that you wish I\u2019d asked you about? Because you just have such a wealth of knowledge.<\/p>\n\n\n\n

Angela Kaida:   <\/strong><\/p>\n\n\n\n

I guess health research and health sciences, needs to involve all of us. I don\u2019t think that\u2019s a controversial statement. And if we are involving all of us, not only will our outcomes be better, our science is better and our opportunity for discovery is higher. And as scientists, that\u2019s where we\u2019re really driven. We have big questions that we\u2019re trying to answer and there are so many opportunities for discovery.<\/p>\n\n\n\n

We have a new Prime Minister in Canada in Mark Carney and he\u2019s encouraging all of us as Canadians to think in different ways about our role as Canadians in a global world.<\/p>\n\n\n\n

And I think one of the things I\u2019ve really come to think deeply about is that investing in women\u2019s health and women\u2019s health research is important for our health, but it\u2019s actually really important for our economy and our economic productivity.<\/p>\n\n\n\n

And so there\u2019s a report by the McKinsey Health group<\/a>. And they have this line that investments in women\u2019s health and women\u2019s health research represent a $1 trillion opportunity in economic potential, driven both by women being healthier and having longer health spans, which we deserve, as well as improving our economic participation and opportunity.<\/p>\n\n\n\n

And so I really think, in this moment, it\u2019s not really about, oh, are there opportunities to do more and to do better? It\u2019s like, yeah, there are big-time opportunities. It\u2019s just, who\u2019s going to seize the moment.<\/p>\n\n\n\n

And so I hope I can just say to your listeners in all of our different ways and power and influence, we all have a role. And so let\u2019s seize this understanding and really catalyze a huge movement and change in Canada.<\/p>\n\n\n\n

Leanne Kaufman:             <\/strong>               <\/p>\n\n\n\n

I think everything that you just said, is just so incredibly important to the whole. It doesn\u2019t matter your sex or your gender. The work that you and your colleagues are undertaking is going to benefit everyone and the society as a whole.<\/p>\n\n\n\n

And thank you for bringing in the even economic impact at the end of our conversation. Because where my mind went when you started talking about health span versus lifespan was, of course, things like stepping out of the workforce and caregiving and all the things that some of our colleagues at Women\u2019s College Hospital talk about in gendered ageism. So we won\u2019t go down that path, but it\u2019s a nice little segue or teaser into some of the other conversations that we have with some of our partners across Canada on this topic.<\/p>\n\n\n\n

Thank you so much, Dr. Kaida, for joining me today. I\u2019ve really, really enjoyed our conversation. And I\u2019ll repeat again just how important the work is that you\u2019re doing and how personally thankful I am that you\u2019re there doing it.<\/p>\n\n\n\n

So, thanks for joining us to help understand the importance of this and addressing these gaps in not just women\u2019s health research in Canada, but sex and gender generally, and why all this matters beyond wealth.<\/p>\n\n\n\n

Angela Kaida:   <\/strong><\/p>\n\n\n\n

Thank you so much, Leanne.<\/p>\n\n\n\n

Leanne Kaufman:<\/strong>            <\/p>\n\n\n\n

You can find out more about Dr. Angela Kaida on the Canadian Institutes of Health Research Institute of Gender and Health site <\/a> and we\u2019ll provide a link in the podcast notes to that, or on LinkedIn<\/a>. And you can learn more about our friends at the Women\u2019s Brain Health Initiative<\/a>, whom we have to thank for the introduction to Dr. Kaida at womensbrainhealth.org<\/a>.<\/p>\n\n\n\n

If you enjoyed this episode and you\u2019d like to help support the podcast, please share it with others, post about it on social media, or leave a rating and review. Until next time, I\u2019m Leanne Kaufman. Thank you for joining us.<\/p>\n\n\n\n

Outro speaker:<\/strong><\/strong><\/p>\n\n\n\n

Whether you are planning for your own estate, the needs of your family or business, or you are an executor for a loved one’s estate, we can help guide you, simplify the complex, and support your life’s vision. Partner with RBC Royal Trust and ensure your legacy will thrive for generations to come. Leave a legacy, not a burden\u2122. Visit rbc.com\/royaltrust<\/a>.<\/p>\n\n\n\n

Thank you for joining us on this episode of Matters Beyond Wealth<\/em>. If you would like more information about RBC Royal Trust, please visit our website at rbc.com\/royaltrust<\/a>.<\/p>\n\n\n\n

\n\n\n\n

Other episodes in this series<\/h2>\n\n\n\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\n
\n\t
\n\t\t
\n\t\t\t

\n\t\t\t\t\n\t\t\t\t\tCan we prevent cardiovascular disease in women?<\/span>\n\t\t\t\t<\/span>\n\t\t\t<\/h3>\n\t\t\t Healthy aging<\/span>\n\t\t\t\n\t\t\t\tJuly 30, 2025\t\t\t\t\t\t\t\t\t|<\/span> Hosted by\t\t\t\t\t\t\t\t\t\t\tLeanne Kaufman<\/a>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\n\t\t\t\t\t25 minute listen
<\/i><\/div>\n\t\t\t\t\t – Can we prevent cardiovascular disease in women? <\/span>\n\t\t\t\t<\/span>\n\t\t\t<\/a>\n\t\t\t\t\t<\/div>\n\t<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\n\t\t\n\n\n
\n

RBC Royal Trust refers to either or both of the Royal Trust Corporation of Canada and or The Royal Trust Company. RBC Royal Trust and RBC Wealth Management are business segments of the Royal Bank of Canada. Please visit https:\/\/www.rbc.com\/legal<\/a> for further information on the entities that are member companies of RBC Wealth Management.  \u00ae\/\u2122 Trademark(s) of Royal Bank of Canada. RBC and Royal Trust are registered trademarks of Royal Bank of Canada. Used under licence. \u00a9 Royal Bank of Canada 2025. All rights reserved.<\/p>\n\n\n\n

This podcast is provided for general information purposes only and is not intended to provide any advice or endorse or recommend any content or third parties referenced in this publication. Further, nothing in this podcast constitutes legal, accounting, estate planning or tax advice and should not be relied upon as such. You are advised to consult with independent tax, legal and professional advisors before taking any action based upon the information contained herein to ensure your own circumstances have been properly considered. While information presented is believed to be factual and current, its accuracy is not guaranteed and it should not be regarded as a complete analysis of the subject matter discussed.<\/p>\n\n\n\n

The information provided in this document is not intended as, nor does it constitute, tax or legal advice. The information provided should only be used in conjunction with a discussion with a qualified legal, tax or other professional advisor when planning to implement a strategy.<\/p>\n\n\n\n

In Quebec, financial planning services are provided by RMFI or RBC WMFS and each is licensed as a financial services firm in that province. In the rest of Canada, financial planning services are available through RMFI or RBC DS. RBC PHNIC, RBC GAM, RBC DS, RBC WMFS, Royal Trust Corporation of Canada and The Royal Trust Company are member companies of RBC Wealth Management, a business segment of Royal Bank of Canada. This document has been prepared by RBC Royal Trust for use by Royal Bank of Canada, Royal Mutual Funds Inc. (\u201cRMFI\u201d), RBC Phillips, Hager & North Investment Counsel Inc. (\u201cRBC PHNIC\u201d), RBC Global Asset Management Inc. (\u201cRBC GAM\u201d), RBC Dominion Securities Inc. (\u201cRBC DS\u201d)*, RBC Wealth Management Financial Services Inc. (\u201cRBC WMFS\u201d), Royal Trust Corporation of Canada and The Royal Trust Company, which are separate corporate entities that are affiliated. * Member\u2013Canadian Investor Protection Fund.


<\/p>\n<\/div><\/div>

<\/div>\n","protected":false},"excerpt":{"rendered":"

Women in Canada control $1.1 trillion of wealth, yet this cohort has long been ignored in health research.<\/p>\n","protected":false},"author":18,"featured_media":0,"template":"","meta":{"_acf_changed":false,"editor_notices":[],"rbc_url_alias":"","footnotes":""},"rbcwm_content_owner":[609],"rbcwm_podcast_category":[484],"rbcwm_podcast_series":[460],"class_list":["post-28810","rbcwm_podcast","type-rbcwm_podcast","status-publish","hentry","rbcwm_content_owner-royal-trust","rbcwm_podcast_category-healthy-aging","rbcwm_podcast_series-matters-beyond-wealth"],"acf":{"rbcwm_custom_breadcrumb_text":"Matters Beyond Wealth","rbcwm_custom_breadcrumb_link":"\/en-ca\/podcasts\/matters-beyond-wealth","rbcwm_subtitle":"Women in Canada control $1.1 trillion of wealth, yet this cohort has long been ignored in health research.","rbcwm_post_author":[1316],"rbcwm_video_id":"6374631740112","rbcwm_video_duration":29,"rbcwm_apple_podcasts_link":"https:\/\/podcasts.apple.com\/ca\/podcast\/closing-the-gaps-in-womens-health-research\/id1647429032?i=1000715457107","rbcwm_spotify_link":"https:\/\/open.spotify.com\/episode\/0tfE1GEKp5yusw5HAMj5Ir?si=J9wlHCWTTWOdoogil_rBjw","rbcwm_download_link":"https:\/\/mcdn.podbean.com\/mf\/download\/ijkdsunyr643ki4c\/matters-beyond-wealth-closing-the-gaps-in-womens-health-research.mp3","rbcwm_post_quote":"\u201cInvesting in women\u2019s health and women\u2019s health research is important for our health, but it\u2019s actually really important for our economy and our economic productivity.\u201d","rbcwm_post_quote_person_name":"Dr. Angela Kaida, Scientific Director, Institute of Gender and Health at the Canadian Institutes of Health Research","rbcwm_other_episodes_alt_title":"Other episodes","rbcwm_matters_beyond_wealth_episodes":null,"rbcwm_custom_breadcrumb_link_url":"\/en-ca\/podcasts\/matters-beyond-wealth","rbcwm_disclaimers":{"add_disclosures":"","perspective_disclaimer":"","expandable":"","omit_from_pages":"","disclaimer_footnote":""},"rbcwm_insight_cta_id":"","rbcwm_pagination":{"next_link":"","next_link_text":"Next article","previous_link":"","previous_link_text":"Previous article"},"article_time":"","rbcwm_enable_toc":false,"rbcwm_toc_selector":"h2"},"yoast_head":"\nMatters Beyond Wealth: Episode 65<\/title>\n<meta name=\"description\" content=\"Women in Canada control $1.1 trillion of wealth, yet this cohort has long been ignored in health research.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rbcwealthmanagement.com\/en-ca\/podcasts\/episode-65-closing-the-gaps-in-womens-health-research\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Closing the gaps in women\u2019s health research\" \/>\n<meta property=\"og:description\" content=\"Women in Canada control $1.1 trillion of wealth, yet this cohort has long been ignored in health research.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rbcwealthmanagement.com\/en-ca\/podcasts\/episode-65-closing-the-gaps-in-womens-health-research\" \/>\n<meta property=\"og:site_name\" content=\"RBC Wealth Management\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-02T15:40:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rbcwealthmanagement.com\/en-ca\/wp-content\/uploads\/sites\/5\/2023\/02\/share-logo-1200x630-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"21 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.rbcwealthmanagement.com\/en-ca\/podcasts\/episode-65-closing-the-gaps-in-womens-health-research\",\"url\":\"https:\/\/www.rbcwealthmanagement.com\/en-ca\/podcasts\/episode-65-closing-the-gaps-in-womens-health-research\",\"name\":\"Matters Beyond Wealth: Episode 65\",\"isPartOf\":{\"@id\":\"https:\/\/www.rbcwealthmanagement.com\/en-ca\/#website\"},\"datePublished\":\"2025-07-02T13:44:40+00:00\",\"dateModified\":\"2025-07-02T15:40:25+00:00\",\"description\":\"Women in Canada control $1.1 trillion of wealth, yet this cohort has long been ignored in health research.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.rbcwealthmanagement.com\/en-ca\/podcasts\/episode-65-closing-the-gaps-in-womens-health-research#breadcrumb\"},\"inLanguage\":\"en-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.rbcwealthmanagement.com\/en-ca\/podcasts\/episode-65-closing-the-gaps-in-womens-health-research\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.rbcwealthmanagement.com\/en-ca\/podcasts\/episode-65-closing-the-gaps-in-womens-health-research#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.rbcwealthmanagement.com\/en-ca\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Closing the gaps in women\u2019s health research\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.rbcwealthmanagement.com\/en-ca\/#website\",\"url\":\"https:\/\/www.rbcwealthmanagement.com\/en-ca\/\",\"name\":\"RBC Wealth Management\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.rbcwealthmanagement.com\/en-ca\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.rbcwealthmanagement.com\/en-ca\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.rbcwealthmanagement.com\/en-ca\/#organization\",\"name\":\"RBC Wealth Management\",\"alternateName\":\"RBC Wealth Management\",\"url\":\"https:\/\/www.rbcwealthmanagement.com\/en-ca\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-CA\",\"@id\":\"https:\/\/www.rbcwealthmanagement.com\/en-ca\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.rbcwealthmanagement.com\/en-ca\/wp-content\/uploads\/sites\/5\/2023\/02\/rbc.png\",\"contentUrl\":\"https:\/\/www.rbcwealthmanagement.com\/en-ca\/wp-content\/uploads\/sites\/5\/2023\/02\/rbc.png\",\"width\":3000,\"height\":2000,\"caption\":\"RBC Wealth Management\"},\"image\":{\"@id\":\"https:\/\/www.rbcwealthmanagement.com\/en-ca\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Matters Beyond Wealth: Episode 65","description":"Women in Canada control $1.1 trillion of wealth, yet this cohort has long been ignored in health research.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rbcwealthmanagement.com\/en-ca\/podcasts\/episode-65-closing-the-gaps-in-womens-health-research","og_locale":"en_US","og_type":"article","og_title":"Closing the gaps in women\u2019s health research","og_description":"Women in Canada control $1.1 trillion of wealth, yet this cohort has long been ignored in health research.","og_url":"https:\/\/www.rbcwealthmanagement.com\/en-ca\/podcasts\/episode-65-closing-the-gaps-in-womens-health-research","og_site_name":"RBC Wealth Management","article_modified_time":"2025-07-02T15:40:25+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.rbcwealthmanagement.com\/en-ca\/wp-content\/uploads\/sites\/5\/2023\/02\/share-logo-1200x630-1.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"21 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.rbcwealthmanagement.com\/en-ca\/podcasts\/episode-65-closing-the-gaps-in-womens-health-research","url":"https:\/\/www.rbcwealthmanagement.com\/en-ca\/podcasts\/episode-65-closing-the-gaps-in-womens-health-research","name":"Matters Beyond Wealth: Episode 65","isPartOf":{"@id":"https:\/\/www.rbcwealthmanagement.com\/en-ca\/#website"},"datePublished":"2025-07-02T13:44:40+00:00","dateModified":"2025-07-02T15:40:25+00:00","description":"Women in Canada control $1.1 trillion of wealth, yet this cohort has long been ignored in health research.","breadcrumb":{"@id":"https:\/\/www.rbcwealthmanagement.com\/en-ca\/podcasts\/episode-65-closing-the-gaps-in-womens-health-research#breadcrumb"},"inLanguage":"en-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rbcwealthmanagement.com\/en-ca\/podcasts\/episode-65-closing-the-gaps-in-womens-health-research"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.rbcwealthmanagement.com\/en-ca\/podcasts\/episode-65-closing-the-gaps-in-womens-health-research#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rbcwealthmanagement.com\/en-ca\/"},{"@type":"ListItem","position":2,"name":"Closing the gaps in women\u2019s health research"}]},{"@type":"WebSite","@id":"https:\/\/www.rbcwealthmanagement.com\/en-ca\/#website","url":"https:\/\/www.rbcwealthmanagement.com\/en-ca\/","name":"RBC Wealth Management","description":"","publisher":{"@id":"https:\/\/www.rbcwealthmanagement.com\/en-ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rbcwealthmanagement.com\/en-ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-CA"},{"@type":"Organization","@id":"https:\/\/www.rbcwealthmanagement.com\/en-ca\/#organization","name":"RBC Wealth Management","alternateName":"RBC Wealth Management","url":"https:\/\/www.rbcwealthmanagement.com\/en-ca\/","logo":{"@type":"ImageObject","inLanguage":"en-CA","@id":"https:\/\/www.rbcwealthmanagement.com\/en-ca\/#\/schema\/logo\/image\/","url":"https:\/\/www.rbcwealthmanagement.com\/en-ca\/wp-content\/uploads\/sites\/5\/2023\/02\/rbc.png","contentUrl":"https:\/\/www.rbcwealthmanagement.com\/en-ca\/wp-content\/uploads\/sites\/5\/2023\/02\/rbc.png","width":3000,"height":2000,"caption":"RBC Wealth Management"},"image":{"@id":"https:\/\/www.rbcwealthmanagement.com\/en-ca\/#\/schema\/logo\/image\/"}}]}},"jetpack_sharing_enabled":true,"publishpress_future_action":{"enabled":false,"date":"2026-04-23 23:31:38","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"rbcwm_content_owner","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"RBC Wealth Management","distributor_original_site_url":"https:\/\/www.rbcwealthmanagement.com\/en-ca","push-errors":false,"last_revision_date":"2026-02-20 13:47:00","_links":{"self":[{"href":"https:\/\/www.rbcwealthmanagement.com\/en-ca\/wp-json\/wp\/v2\/rbcwm_podcast\/28810","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rbcwealthmanagement.com\/en-ca\/wp-json\/wp\/v2\/rbcwm_podcast"}],"about":[{"href":"https:\/\/www.rbcwealthmanagement.com\/en-ca\/wp-json\/wp\/v2\/types\/rbcwm_podcast"}],"author":[{"embeddable":true,"href":"https:\/\/www.rbcwealthmanagement.com\/en-ca\/wp-json\/wp\/v2\/users\/18"}],"version-history":[{"count":17,"href":"https:\/\/www.rbcwealthmanagement.com\/en-ca\/wp-json\/wp\/v2\/rbcwm_podcast\/28810\/revisions"}],"predecessor-version":[{"id":31808,"href":"https:\/\/www.rbcwealthmanagement.com\/en-ca\/wp-json\/wp\/v2\/rbcwm_podcast\/28810\/revisions\/31808"}],"acf:post":[{"embeddable":true,"href":"https:\/\/www.rbcwealthmanagement.com\/en-ca\/wp-json\/wp\/v2\/rbcwm_people\/1316"}],"wp:attachment":[{"href":"https:\/\/www.rbcwealthmanagement.com\/en-ca\/wp-json\/wp\/v2\/media?parent=28810"}],"wp:term":[{"taxonomy":"rbcwm_content_owner","embeddable":true,"href":"https:\/\/www.rbcwealthmanagement.com\/en-ca\/wp-json\/wp\/v2\/rbcwm_content_owner?post=28810"},{"taxonomy":"rbcwm_podcast_category","embeddable":true,"href":"https:\/\/www.rbcwealthmanagement.com\/en-ca\/wp-json\/wp\/v2\/rbcwm_podcast_category?post=28810"},{"taxonomy":"rbcwm_podcast_series","embeddable":true,"href":"https:\/\/www.rbcwealthmanagement.com\/en-ca\/wp-json\/wp\/v2\/rbcwm_podcast_series?post=28810"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}